These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20023913)

  • 21. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel bis(thiosemicarbazones) of the 3,5-diacetyl-1,2,4-triazol series and their platinum(II) complexes: chemistry, antiproliferative activity and preliminary nephrotoxicity studies.
    Matesanz AI; Hernández C; Rodríguez A; Souza P
    Dalton Trans; 2011 Jun; 40(21):5738-45. PubMed ID: 21519595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties.
    Liu P; Lu Y; Gao X; Liu R; Zhang-Negrerie D; Shi Y; Wang Y; Wang S; Gao Q
    Chem Commun (Camb); 2013 Mar; 49(24):2421-3. PubMed ID: 23420130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
    Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.
    Thiabaud G; McCall R; He G; Arambula JF; Siddik ZH; Sessler JL
    Angew Chem Int Ed Engl; 2016 Oct; 55(41):12626-31. PubMed ID: 27377046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
    Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
    Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide targeting of platinum anti-cancer drugs.
    Ndinguri MW; Solipuram R; Gambrell RP; Aggarwal S; Hammer RP
    Bioconjug Chem; 2009 Oct; 20(10):1869-78. PubMed ID: 19775102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
    Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
    Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization, and cytotoxic activity of novel platinum (II) complexes derived from n-benzyl-ethylenediamine and oxalate.
    Silva H; Barra CV; Rocha FV; de Almeida MV; Cesar ET; da Silva Siqueira LM; Lopes MT; Fontes AP
    Chem Biol Drug Des; 2010 Apr; 75(4):407-11. PubMed ID: 20102368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
    Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
    J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Multi-action and Multi-target Ru
    Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent.
    Bernhard EJ; Mitchell JB; Deen D; Cardell M; Rosenthal DI; Brown JM
    Cancer Res; 2000 Jan; 60(1):86-91. PubMed ID: 10646858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death.
    Yang L; Bose S; Ngo AH; Do LH
    ChemMedChem; 2017 Feb; 12(4):292-299. PubMed ID: 28052592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
    Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
    Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
    Rosenthal DI; Nurenberg P; Becerra CR; Frenkel EP; Carbone DP; Lum BL; Miller R; Engel J; Young S; Miles D; Renschler MF
    Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide donor-based platinum complexes as potential anticancer agents.
    Zhao J; Gou S; Sun Y; Yin R; Wang Z
    Chemistry; 2012 Nov; 18(45):14276-81. PubMed ID: 23015473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and biological evaluation of platinum(II) complexes with a chiral N-monosubstituted 1,2-cyclohexyldiamine derivative.
    Gao C; Gou S; Xu G
    Chem Pharm Bull (Tokyo); 2011; 59(7):851-4. PubMed ID: 21720035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.